Ruzotolimod (RO7020531) is an orally active Toll-like receptor 7 agonist that suppresses WHV replication and, in combination with RO-7049389, significantly reduces AAV-HBV viral load, while also serving as an experimental immunomodulatory agent for studying antiviral innate immune responses and therapeutic strategies relevant to SARS-CoV-2 and COVID-19 infection models.
Molecular Weight:
354.38
CAS Number:
[1948241-60-8]
Formula:
C14H18N4O5S
Target:
TLR
T61260
* VAT and and shipping costs not included. Errors and price changes excepted